The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
New research effort to translate basic science into faster bone healing

Researchers from the University of Rochester Medical Center have received a $7.8 million grant to speed the conversion of basic bone science into new treatments that prevent arthritis, improve fracture healing and save limbs. In one case, the research aims to confirm preliminary findings that a handful of patients, previously confined to wheelchairs by fractures that would not heal, were able to walk again after receiving a drug treatment that finally healed the bone.

The award is the first of its kind, a Center of Research Translation (CORT) grant in orthopaedics from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. It is part of a larger effort by the National Institutes of Health (NIH) to fast-track basic scientific findings into meaningful clinical treatments (translational research). With this latest grant, the Department of Orthopaedics and Rehabilitation at the Medical Center becomes the best funded of its kind in the nation in terms of NIH research dollars, according to a new ranking for the most recent NIH fiscal year.

The Rochester CORT will explore new ways to heal trauma to bone and cartilage caused by aging and injury. About 3.6 million Americans suffer trauma to bones or soft tissue each year, with the worst damage caused by car crashes, gunshot wounds and falls. The number of orthopaedic injuries has increased in recent years as baby boomers age, and as U.S. soldiers in Iraq continue to suffer severe injuries.

"We are getting close to the point where decades of research finally pay off in new treatments that restore trauma patients' ability to walk and use their limbs," said Randy N. Rosier, M.D., Ph.D., chair of the Department of Orthopaedics and Rehabilitation at the Medical Center. "We believe our new center will play a key role in a nationwide effort to reverse long-term disability," said Rosier, also principal investigator for the grant.

Research Highlights

Led by R
'"/>

Contact: Greg Williams
Greg_Williams@urmc.rochester.edu
University of Rochester Medical Center
19-Oct-2006


Page: 1 2 3 4

Related medicine news :

1. 1 of 2 pediatric kidney disease research centers in world established
2. Stanford researchers find culprit in aging muscles that heal poorly
3. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
4. Indiana University Imaging Center receives $6M grant for kidney research
5. Penn researchers discover novel pathway for increasing good cholesterol
6. New research discovers independent brain networks control human walking
7. Theory of facial aging gets a facelift from UT Southwestern researchers
8. Sports concussion research using fMRI provides insight for safe return-to-play decisions
9. UIC researchers to develop new drugs to fight bioterrorism
10. New research finds high prevalence of smoking among physicians in China
11. Fat is the new normal, FSU researcher says

Post Your Comments:
(Date:11/25/2009)...o signaling pathways essential to normal human dev...owth factor receptor (EGFR) pathways - interact in...astasis, researchers from The University of Texas ... issue of Molecular Cell . , This newly charact...ents known to correlate with invasive cancer - act...
(Date:11/25/2009)...ov. 25, 2009) Melvin R. Kaplan, MD, FACP, a forme...rch institute that became Los Angeles Biomedical R...A BioMed), will be honored by the American College...re of patients. , At its April 22, 2010 meeting ...l present Dr. Kaplan with the Ralph O. Claypoole S...
(Date:11/25/2009)...5, 2009 Physicians at UT Southwestern Medical Cen...ed to improve breathing in patients with upper spi... from breathing independently. , UT Southwester...y two sites in Texas and one of 25 in the country ...he NeuRx Diaphragm Pacing System. , The device i...
(Date:11/25/2009)...tify role mitochondrial function plays in insulin ...hDay News) -- Mitochondrial damage causes people w...s, a finding that could lead to new treatments, U....gy for cellular activity. , The researchers fou...ancreas can,t respond to circulating insulin, it t...
(Date:11/25/2009)... PCU College teaches students to use natu... , Burnaby, BC (Vocus) No... radiation are the standard, effective treatments ...o alternative medicine to help them cope with the ...creased number of cancer patients using acupunctur...
Breaking Medicine News(10 mins):Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Holistic and Western Medicine Combined Can Fight Cancer 2
(Date:11/25/2009)...DIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(...opingproductsforminimallydisruptivesurgicaltreatme...encecallonMonday,November30,2009,at5:30p.m.ET/2:30...lativetoreimbursementfortheCompany,sproductsandwil...tionandanswersession.Thedial-innumbersare1-877-407...
(Date:11/25/2009)...MINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall...IN),aleadinginnovatorandprovideroflessinvasive,min...zingthetreatmentofadvancedheartfailure,todayannoun...the21stAnnualPiperJaffrayHealthCareConferenceat8:0...ingheldattheNewYorkPalaceHotel,December1-2. ,, ...
(Date:11/24/2009)...ISON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagn...oviderofdiagnostictesting,informationandservices,a...erJaffrayHealthcareConferenceinNewYorkCity.Thepres...30a.m.EasternTime. ,, Duringtheconference,theco...approximate3%,operatingincometoexceed18%ofrevenues...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP 6124 Phase Ib IIa Trial at the International Conference on Alzheimers Diseas 13042 1EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP 6124 Phase Ib IIa Trial at the International Conference on Alzheimers Diseas 13042 2Rare Cells Linked to Pediatric Cancers 51764 1Rare Cells Linked to Pediatric Cancers 51764 2Stem Cell Decision Opens New Doors May Spur More Research 51762 1Stem Cell Decision Opens New Doors May Spur More Research 51762 2Stem Cell Decision Opens New Doors May Spur More Research 51762 3
Other News:
...5, 28 of the world's leading diabetes researchers ...Biological Sciences Learning Center, 924 E. 57th S...ebrate the 75th birthday of Donald F. Steiner, M.D... Molecular Biology and a member of the Howard Hugh...
ADULT lifestyle has more influence on your chances of developing diabetes than childhood experience, according to new research whose findings contradict previously-held beliefs. ......A team from the
...here is no specific PSA value that has both high s...lthy men for prostate cancer, but rather there is ...of PSA, according to a study in the July 6 issue o...ing activities in the United States is the measure...
...ol may allow healthcare professionals treating chi...more systematically sort out the combination of tr...hildren may improve over time. If the model holds ... to gauge the effectiveness of different autism tr...
health news:Steiner symposium brings together leading diabetes experts 2health news:Steiner symposium brings together leading diabetes experts 3health news:Adult lifestyle biggest risk factor for diabetes, study finds 2health news:Study examines accuracy of PSA values for detecting prostate cancer 2health news:Study examines accuracy of PSA values for detecting prostate cancer 3health news:New model may better predict outcomes for children with autism and autistic spectrum disorders 2health news:New model may better predict outcomes for children with autism and autistic spectrum disorders 3
...clinical trial for patients with advanced colorect...ontaining the investigational drug oxaliplatin liv...d therapy. Patients on the oxaliplatin regimen, k...ir tumors progressed, a better response rate, and ...
...ell, M.D., jokingly call their treatment table the... then a close brush with mortality entitles these ... they want....... Humor aside, they have come to t...st hope of preserving their lives, if not their br...
...EST) An experimental pill has been found to impro...on-small-cell lung cancer, according to research f...g Medical Director at Cedars-Sinai Comprehensive C...ill, called ZD 1839 (Iressa) is one of a new class...
...or inoperable primary liver cancer called TheraSph...cer patients, according to results presented by a ...nual Meeting of the American Society for Clinical ...fessor and director of the liver tumor service at ...
health news:New drug regimen shows clear benefit for treating advanced colorectal cancer 2health news:New drug regimen shows clear benefit for treating advanced colorectal cancer 3health news:New breast cancer therapy trials show dramatic results 2health news:New breast cancer therapy trials show dramatic results 3health news:New breast cancer therapy trials show dramatic results 4health news:New breast cancer therapy trials show dramatic results 5health news:Experimental pill found to improve symptoms in patients with non-small-cell lung cancer 2health news:Experimental pill found to improve symptoms in patients with non-small-cell lung cancer 3health news:New treatment reduces liver tumors and improves quality of life for cancer patients 2